JP2000506876A - 2―(3h)―オキサゾロン誘導体およびcox―2阻害剤としてのそれらの使用 - Google Patents
2―(3h)―オキサゾロン誘導体およびcox―2阻害剤としてのそれらの使用Info
- Publication number
- JP2000506876A JP2000506876A JP9533156A JP53315697A JP2000506876A JP 2000506876 A JP2000506876 A JP 2000506876A JP 9533156 A JP9533156 A JP 9533156A JP 53315697 A JP53315697 A JP 53315697A JP 2000506876 A JP2000506876 A JP 2000506876A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- alkyl
- compound
- oxazolone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式(I): 式中: R1はアルキルもしくは−NR4R5基であり、ここでR4およびR5は各々独立 して水素あるいはアルキルもしくはベンジル基であり; R2はナフチル、テトラヒドロナフチル、置換されていないフェニル、あるい は1〜3のハロゲン元素またはアルキル、ヒドロキシ、アルコキシ、もしくはト リフルオロメチル基により置換されたフェニル基であり;そして R3は水素もしくはアルキル基である、の2−(3H)−オキサゾロン化合物 。 2. R2が2−ナフチル基または1もしくは2のハロゲン原子により置換さ れるフェニル基である、請求の範囲1に記載の化合物。 3. R2が1〜3の塩素もしくはフッ素原子により置換されるフェニル基で ある、請求の範囲1もしくは2に記載の化合物。 4. アルキル基もしくは部分が1〜6の炭素原子を含む先行する請求の範囲 の内のいずれか一つに記載の化合物。 5. 3−(4−フルオロフェニル)−4−(4−メチルスルホニルフェニル )−2−(3H)−オキサゾロン; 3−(2−フルオロフェニル)−4−(4−アミノスルホニルフェニル)−2− (3H)−オキサゾロン; 3−(3,4−ジクロロフェニル)−4−(4−アミノスルホニルフェニル)− 2−(3H)−オキサゾロン;および 3−(2,4−ジフルオロフェニル)−4−(4−アミノスルホニルフェニル) −2−(3H)−オキサゾロン。 6. a)R1がアルキルもしくは−NR4R5基であり、この式中R4およびR5 が水素以外である場合には、式(V): 式中、R2およびR3は請求の範囲1に定義されたとおりであり、そしてR1aはア ルキルもしくは−NR4aR5a基であり、ここでR4aとR5aは各々独立にアルキル もしくはベンジル基である、のカルバメートを無水酢酸と反応させること; b)R1がアルキル基である場合には、式(VIII): 式中、R2およびR3は請求の範囲1に定義されたとおりであり、そしてR1bはア ルキル基である、のメルカプト誘導体を酸化剤と反応させること; c)R1が−NR4R5基であり、ここでR4およびR5が請求の 範囲1に定義されたとおりである場合には、式(XI): 式中、R2およびR3は請求の範囲1に定義されたとおりである、のクロロスルホ ニル誘導体を、式(XII): R4 − NH − R5 (XII) 式中R4およびR5は先に定義されたとおりである、のアミンと反応させること; あるいは d)R1が−NR4R5基であり、ここでR4およびR5が水素である場合 には、式(IX): 式中、R2、R3、R4、およびR5は請求の範囲1に定義されたとおりであるがた だし、R4とR5の内の少なくとも一つがベンジル基である、の対応化合物を脱ベ ンジル化すること、 を含む、先行する請求の範囲の内のいずれか一つにおいて定義される式(I)の 化合物の製造方法。 7. 有効成分として少なくとも一つの請求の範囲1〜5の内のいずれか一つ において定義される式(I)の化合物、および薬剤学的に許容 される担体もしくは賦形剤を含む薬剤学的組成物。 8. 治療によるヒトもしくは動物の体の処置の方法において使用するための 請求の範囲1〜5の内のいずれか一つにおいて定義される式(I)の化合物。 9. 疼痛、発熱、もしくは炎症の処置、プロスタノイドにより誘導される平 滑筋収縮の阻害、または結腸直腸癌の予防のために使用するための、請求の範囲 1〜5の内のいずれか一つにおいて定義される式(I)の化合物。 10. 疼痛、発熱、もしくは炎症の処置、プロスタノイドにより誘導される平 滑筋収縮の阻害、または結腸直腸癌の予防のための薬剤の製造における、請求の 範囲1〜5の内のいずれか一つにおいて定義される式(I)の化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009600685A ES2125161B1 (es) | 1996-03-21 | 1996-03-21 | Nuevos derivados de 2-(3h)-oxazolona. |
ES9600685 | 1996-03-21 | ||
PCT/EP1997/001386 WO1997034882A1 (en) | 1996-03-21 | 1997-03-19 | 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000506876A true JP2000506876A (ja) | 2000-06-06 |
JP3810091B2 JP3810091B2 (ja) | 2006-08-16 |
Family
ID=8294266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53315697A Expired - Fee Related JP3810091B2 (ja) | 1996-03-21 | 1997-03-19 | 2―(3h)―オキサゾロン誘導体およびcox―2阻害剤としてのそれらの使用 |
Country Status (30)
Country | Link |
---|---|
US (1) | US6869968B1 (ja) |
EP (1) | EP0888316B1 (ja) |
JP (1) | JP3810091B2 (ja) |
KR (1) | KR100496395B1 (ja) |
CN (1) | CN1110488C (ja) |
AR (1) | AR006340A1 (ja) |
AT (1) | ATE197294T1 (ja) |
AU (1) | AU713811B2 (ja) |
BR (1) | BR9708141A (ja) |
CA (1) | CA2249420A1 (ja) |
CO (1) | CO4780046A1 (ja) |
CZ (1) | CZ294963B6 (ja) |
DE (1) | DE69703437T2 (ja) |
DK (1) | DK0888316T3 (ja) |
ES (2) | ES2125161B1 (ja) |
GR (1) | GR3035096T3 (ja) |
HK (1) | HK1015371A1 (ja) |
ID (1) | ID16778A (ja) |
IL (1) | IL126206A (ja) |
NO (1) | NO311761B1 (ja) |
NZ (1) | NZ331901A (ja) |
PE (1) | PE42898A1 (ja) |
PL (1) | PL188722B1 (ja) |
PT (1) | PT888316E (ja) |
RU (1) | RU2194043C2 (ja) |
TW (1) | TW426674B (ja) |
UA (1) | UA52645C2 (ja) |
UY (1) | UY24499A1 (ja) |
WO (1) | WO1997034882A1 (ja) |
ZA (1) | ZA972203B (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2125161B1 (es) | 1996-03-21 | 1999-11-16 | Grupo Farmaceutico Almirall S | Nuevos derivados de 2-(3h)-oxazolona. |
FR2753449B1 (fr) * | 1996-09-13 | 1998-12-04 | Union Pharma Scient Appl | Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique |
ES2131015B1 (es) * | 1997-09-12 | 2000-03-01 | Almirall Prodesfarma Sa | Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas. |
ES2168895A1 (es) * | 1999-03-26 | 2002-06-16 | Almirall Prodesfarma Sa | Derivados de 2-fenilpiran-4-ona. |
ES2154561B1 (es) * | 1998-09-25 | 2001-12-01 | Almirall Prodesfarma Sa | Derivados de 2-fenilpiran-4-ona. |
IL150368A0 (en) | 1999-12-23 | 2002-12-01 | Nitromed Inc | Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use |
US20030105144A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
WO2004002420A2 (en) | 2002-06-28 | 2004-01-08 | Nitromed, Inc. | Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
ES2215474B1 (es) | 2002-12-24 | 2005-12-16 | J. URIACH & CIA S.A. | Nuevos derivados de fosforamida. |
ES2213485B1 (es) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
PL1534305T3 (pl) | 2003-05-07 | 2007-03-30 | Osteologix As | Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie |
CN1309717C (zh) * | 2003-06-03 | 2007-04-11 | 李小虎 | 4-芳基-5h-噻吩-2-酮衍生物、其制法和用途 |
EP2114461A2 (en) * | 2007-01-19 | 2009-11-11 | Mallinckrodt Inc. | Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4866182A (en) | 1988-02-18 | 1989-09-12 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic alkanoyl and aroyl oxazolones |
US5380738A (en) | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
DE4435547A1 (de) | 1994-10-05 | 1996-04-11 | Bayer Ag | Sulfonylaminocarbonyltriazolinone mit über Sauerstoff und Schwefel gebundenen Substituenten |
JP2636819B2 (ja) | 1994-12-20 | 1997-07-30 | 日本たばこ産業株式会社 | オキサゾール系複素環式芳香族化合物 |
ES2125161B1 (es) | 1996-03-21 | 1999-11-16 | Grupo Farmaceutico Almirall S | Nuevos derivados de 2-(3h)-oxazolona. |
FR2753449B1 (fr) * | 1996-09-13 | 1998-12-04 | Union Pharma Scient Appl | Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique |
-
1996
- 1996-03-21 ES ES009600685A patent/ES2125161B1/es not_active Expired - Lifetime
-
1997
- 1997-03-13 ZA ZA9702203A patent/ZA972203B/xx unknown
- 1997-03-19 PT PT97915396T patent/PT888316E/pt unknown
- 1997-03-19 AU AU22893/97A patent/AU713811B2/en not_active Ceased
- 1997-03-19 IL IL12620697A patent/IL126206A/en not_active IP Right Cessation
- 1997-03-19 UA UA98094878A patent/UA52645C2/uk unknown
- 1997-03-19 AT AT97915396T patent/ATE197294T1/de not_active IP Right Cessation
- 1997-03-19 WO PCT/EP1997/001386 patent/WO1997034882A1/en active IP Right Grant
- 1997-03-19 BR BR9708141A patent/BR9708141A/pt active Search and Examination
- 1997-03-19 DE DE69703437T patent/DE69703437T2/de not_active Expired - Fee Related
- 1997-03-19 TW TW086103412A patent/TW426674B/zh not_active IP Right Cessation
- 1997-03-19 PL PL97328915A patent/PL188722B1/pl not_active IP Right Cessation
- 1997-03-19 RU RU98119076/04A patent/RU2194043C2/ru not_active IP Right Cessation
- 1997-03-19 CA CA002249420A patent/CA2249420A1/en not_active Abandoned
- 1997-03-19 CN CN97194660A patent/CN1110488C/zh not_active Expired - Fee Related
- 1997-03-19 DK DK97915396T patent/DK0888316T3/da active
- 1997-03-19 KR KR10-1998-0707459A patent/KR100496395B1/ko not_active IP Right Cessation
- 1997-03-19 NZ NZ331901A patent/NZ331901A/en unknown
- 1997-03-19 JP JP53315697A patent/JP3810091B2/ja not_active Expired - Fee Related
- 1997-03-19 CZ CZ19982979A patent/CZ294963B6/cs not_active IP Right Cessation
- 1997-03-19 EP EP97915396A patent/EP0888316B1/en not_active Expired - Lifetime
- 1997-03-19 ES ES97915396T patent/ES2151254T3/es not_active Expired - Lifetime
- 1997-03-20 ID IDP970904A patent/ID16778A/id unknown
- 1997-03-20 CO CO97015097A patent/CO4780046A1/es unknown
- 1997-03-21 PE PE1997000228A patent/PE42898A1/es not_active Application Discontinuation
- 1997-03-21 AR ARP970101133A patent/AR006340A1/es not_active Application Discontinuation
- 1997-03-21 UY UY24499A patent/UY24499A1/es not_active IP Right Cessation
-
1998
- 1998-09-17 NO NO19984325A patent/NO311761B1/no unknown
- 1998-09-21 US US09/158,966 patent/US6869968B1/en not_active Expired - Fee Related
-
1999
- 1999-02-08 HK HK99100521A patent/HK1015371A1/xx not_active IP Right Cessation
-
2000
- 2000-12-18 GR GR20000402784T patent/GR3035096T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000506876A (ja) | 2―(3h)―オキサゾロン誘導体およびcox―2阻害剤としてのそれらの使用 | |
CZ274996A3 (en) | Heterocyclic aromatic oxazole compounds, their oxime, ketone, ketonemethylene, ester and amide compounds, pharmaceutical preparations, cyclooxygenase inhibitors and antiphlogistic agents in which said oxazole compounds are comprised | |
JPH09505829A (ja) | 炎症および炎症関連障害を処置するための1,4,5−トリフェニルピラゾリル化合物 | |
JP2003513961A (ja) | シクロオキシゲナーゼ−2の阻害剤である5−アリール−1h−1,2,4−トリアゾール化合物とそれを含む医薬品組成物 | |
JP2005516009A (ja) | 重水素化された置換ピラゾリル−ベンゼンスルホンアミド並びにこれを含有する医薬品 | |
JP2000501411A (ja) | ベンゾフランカルボキサミドおよびスルホンアミド | |
RU2232158C2 (ru) | Производные 2-фенилпиран-4-она, фармацевтическая композиция на их основе и способ лечения | |
JP2000515161A (ja) | 新規の炭素環式ジアリールメチレン誘導体、その製造方法及びその治療上の使用 | |
JP2001516750A (ja) | 新規な2−(3h)−オキサゾロン誘導体 | |
US9079876B2 (en) | Imidazole derivatives and preparation method and use thereof | |
US20060189684A1 (en) | 3-Phenylfuran-2-one derivatives as cox-2 inhibitor | |
JP2003528086A (ja) | 抗炎症活性を有する新規イミダゾール誘導体 | |
MXPA97001944A (en) | New derivatives of 2- (3h) -oxazole | |
UA73288C2 (en) | 2-phenylpyran-4-one derivatives | |
JPS5848556B2 (ja) | 亜鉛化合物およびその製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051018 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060111 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060227 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060327 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060516 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060523 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100602 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100602 Year of fee payment: 4 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100602 Year of fee payment: 4 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |